by Randy E. Miller | Jul 24, 2024 | FOIA, FTC, Medical Devices, Pharmaceuticals
FOIAengine Reveals Inquiries About FTC’s Inner Workings With the Federal Trade Commission reportedly preparing to sue the three largest pharmacy benefit managers, or PBMs, over their approach to negotiating the availability and prices for drugs, we’re taking a look...
by Randy E. Miller | Jul 3, 2024 | FDA, FOIA, Law Firms, Litigation, Pharmaceuticals
FOIAengine: Law Firm’s 48 Inquiries Follow Earlier Requests Personal injury law firm Morgan & Morgan continued to push the Food and Drug Administration during May for documents that could strengthen potential litigation challenging popular weight control drugs. ...
by Randy E. Miller | Jun 27, 2024 | FDA, FOIA, SEC
FOIAengine Reveals Trends Behind the Big Numbers at FDA, SEC This week we analyze the sources of Freedom of Information Act requests made during May to the Food and Drug Administration and the Securities and Exchange Commission. This analysis provides a macro view...
by Randy E. Miller | May 30, 2024 | FDA, FOIA, Hedge Funds, News Media, Pharmaceuticals, Stock Market
FOIAengine: Requests Show FDA Still Under Pressure This week, we’re taking a closer look at the numerous Freedom of Information Act requests recently filed with the Food and Drug Administration concerning the problematic India pharmaceutical industry. As we noted in...
by Randy E. Miller | Apr 24, 2024 | FDA, FOIA, News Media, SEC
FOIAengine: Insights From the Latest FDA and SEC Requests News media outlets are among the most prolific submitters of FOIA requests to federal agencies. These requests signal – in real time – the stories that journalists are researching and writing. To illustrate...
